{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:05:11Z","timestamp":1795028711145,"version":"4.10.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Progetto ricerca corrente"],"award-info":[{"award-number":["Progetto ricerca corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recessive dystrophic epidermolysis bullosa (RDEB) is a rare and severe mucocutaneous fragility disorder due to mutations in the\n                      <jats:italic>COL7A1<\/jats:italic>\n                      gene encoding collagen VII, the major constituent of anchoring fibrils essential for epithelial adhesion. RDEB is characterized by unremitting blistering, chronic painful wounds and fibrotic scarring that results in hand and foot pseudosyndactyly, microstomia, and esophageal strictures. RDEB complications include nutritional compromise, chronic anemia, failure to thrive, delayed puberty, osteoporosis, and renal involvement. In addition, early onset cutaneous squamous cell carcinomas (cSCC) represent the first cause of premature death. Despite recent progress in wound care, disease management still relies on symptomatic and preventive measures. No clinical practice guidelines specifically focused on the care of RDEB are currently available. The present multidisciplinary consensus recommendations were generated following a modified Delphi method with the aim to provide healthcare professionals with practical statements on RDEB management from birth to adulthood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten experts from six Italian EB reference centers developed 86 statements based on existing clinical practice guidelines and consensus recommendations for EB, literature data, and personal expertise. A multidisciplinary group of 30 members, representative of all major specialties relevant to RDEB management, participated to the anonymous online voting process. All statements reached consensus (&gt;\u200975% agreement) at first voting round. Statements are divided into four major areas: (1) diagnosis, (2) neonatal age and infancy, (3) from childhood to adulthood, and (4) transversal age-independent issues, each of the last three comprising multiple domains of care. In particular, the section on patient care from childhood to adults deals with measures for management of wounds, gastrointestinal, eye and renal involvement, nutritional compromise, anemia, hand and foot deformities, cSCC, delayed puberty and osteoporosis, sexuality, pregnancy and delivery. Transversal issues comprise: pain and itch management, patient care in the operating theatre, physiotherapy and occupational therapy, therapeutic patient education and psychosocial support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The proposed practical and synthetic recommendations cover all major issues in the management of patients with RDEB from birth to adulthood. They can represent a useful tool to support hospital healthcare personnel as well as primary care physicians in the complex multidisciplinary management of RDEB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03635-1","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T16:14:16Z","timestamp":1742141656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Taking care of patients with recessive dystrophic epidermolysis bullosa from birth to adulthood: a multidisciplinary Italian Delphi consensus"],"prefix":"10.1186","volume":"20","author":[{"given":"May","family":"El Hachem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-9825","authenticated-orcid":false,"given":"Andrea","family":"Diociaiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bonamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Brena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Lospalluti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Tadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Zambruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Delphi Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Caldaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Depenni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Diamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"Femino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fiorentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gabusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Galeotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gelmetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Giavoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Guez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Laforgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Laterza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lucaccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Massella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Parolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Reali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Salera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Taurisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziamaria","family":"Ubertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Vimercati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Volante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,16]]},"reference":[{"key":"3635_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has C, Bauer JW, Bodemer C, Bolling MC, Bruckner-Tuderman L, Diem A, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183:614\u201327.","journal-title":"Br J Dermatol"},{"key":"3635_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bjd.18128","volume":"182","author":"C Has","year":"2020","unstructured":"Has C, Liu L, Bolling MC, Charlesworth AV, El Hachem M, Esc\u00e1mez MJ, et al. Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa. Br J Dermatol. 2020;182:574\u201392.","journal-title":"Br J Dermatol"},{"key":"3635_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan A, Bruckner-Tuderman L, Chapple ILC, Fine JD, Harper N, Has C, et al. Epidermolysis bullosa. Nat Rev Dis Primers. 2020;6:78.","journal-title":"Nat Rev Dis Primers"},{"key":"3635_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","volume":"152","author":"JD Fine","year":"2016","unstructured":"Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry. JAMA Dermatol. 2016;152:1231\u20138.","journal-title":"JAMA Dermatol"},{"key":"3635_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jdv.17012","volume":"35","author":"R Baardman","year":"2021","unstructured":"Baardman R, Yenamandra VK, Duipmans JC, Pasmooji AMG, Jonkman MF, van den Akker PC, et al. Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed? J Eur Acad Dermatol Venereol. 2021;35:995\u20131006.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3635_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/bjd.20958","volume":"186","author":"G Petrof","year":"2022","unstructured":"Petrof G, Papanikolaou M, Martinez AE, Mellerio JE, McGrath JA, Bardhan A, et al. The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database. Br J Dermatol. 2022;186:843\u20138.","journal-title":"Br J Dermatol"},{"key":"3635_CR7","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.3390\/ijms22105104","volume":"22","author":"G Tartaglia","year":"2021","unstructured":"Tartaglia G, Cao Q, Padron ZM, South AP. Impaired wound healing, fibrosis, and cancer: the paradigm of recessive dystrophic epidermolysis bullosa. Int J Mol Sci. 2021;22:5104.","journal-title":"Int J Mol Sci"},{"key":"3635_CR8","doi-asserted-by":"publisher","first-page":"737272","DOI":"10.3389\/fgene.2021.737272","volume":"12","author":"A Nystr\u00f6m","year":"2021","unstructured":"Nystr\u00f6m A, Bruckner-Tuderman L, Kiritsi D. Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers. Front Genet. 2021;12:737272.","journal-title":"Front Genet"},{"key":"3635_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13023-021-01811-7","volume":"16","author":"JY Tang","year":"2021","unstructured":"Tang JY, Marinkovich MP, Lucas E, Gorell E, Chiou A, Lu Y, et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2021;16:175.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/cells11081365","volume":"11","author":"D Bonamonte","year":"2022","unstructured":"Bonamonte D, Filoni A, De Marco A, Lospalluti L, Nacchiero E, Ronghi V, et al. Squamous cell carcinoma in patients with inherited epidermolysis bullosa: review of current literature. Cells. 2022;11:1365.","journal-title":"Cells"},{"key":"3635_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/TCRM.S386923","volume":"19","author":"PC Hou","year":"2023","unstructured":"Hou PC, Del Agua N, Lwin SM, Hsu CK, McGrath JA. Innovations in the treatment of dystrophic epidermolysis bullosa (DEB): current landscape and prospects. Ther Clin Risk Manag. 2023;19:455\u201373.","journal-title":"Ther Clin Risk Manag"},{"key":"3635_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/bjd\/ljac001","volume":"188","author":"JS Kern","year":"2023","unstructured":"Kern JS, Sprecher E, Fernandez MF, Schauer F, Bodemer C, Cunningham T, et al. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study. Br J Dermatol. 2023;188:12\u201321.","journal-title":"Br J Dermatol"},{"key":"3635_CR13","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa2206663","volume":"387","author":"SV Guide","year":"2022","unstructured":"Guide SV, Gonzalez ME, Ba\u011fc\u0131 IS, Agostini B, Chen H, Feeney G, et al. Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa. N Engl J Med. 2022;387:2211\u20139.","journal-title":"N Engl J Med"},{"key":"3635_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaad.2012.01.016","volume":"67","author":"E Pope","year":"2012","unstructured":"Pope E, Lara-Corrales I, Mellerio J, Martinez A, Schultz G, Burrell R, et al. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol. 2012;67:904\u201317.","journal-title":"J Am Acad Dermatol"},{"key":"3635_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1750-1172-9-76","volume":"9","author":"M El Hachem","year":"2014","unstructured":"El Hachem M, Zambruno G, Bourdon-Lanoy E, Ciasulli A, Buisson C, Hadj-Rabia S, et al. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis. 2014;9:76.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12916-014-0178-2","volume":"12","author":"KR Goldschneider","year":"2014","unstructured":"Goldschneider KR, Good J, Harrop E, Liossi C, Lynch-Jordan A, Martinez AE, et al. Dystrophic Epidermolysis Bullosa Research Association International (DEBRA International). Pain care for patients with epidermolysis bullosa: best care practice guidelines. BMC Med. 2014;12:178.","journal-title":"BMC Med"},{"key":"3635_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/bjd.14104","volume":"174","author":"JE Mellerio","year":"2016","unstructured":"Mellerio JE, Robertson SJ, Bernardis C, Diem A, Fine JD, George R, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Br J Dermatol. 2016;174:56\u201367.","journal-title":"Br J Dermatol"},{"key":"3635_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13023-019-1059-8","volume":"14","author":"JM Chan","year":"2019","unstructured":"Chan JM, Weisman A, King A, Maksomski S, Shotwell C, Bailie C, et al. Occupational therapy for epidermolysis bullosa: clinical practice guidelines. Orphanet J Rare Dis. 2019;14:129.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13023-019-1086-5","volume":"14","author":"K Martin","year":"2019","unstructured":"Martin K, Geuens S, Asche JK, Bodan R, Browne F, Downe A, et al. Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines. Orphanet J Rare Dis. 2019;14:133.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/bjd.18381","volume":"182","author":"MT Khan","year":"2020","unstructured":"Khan MT, O\u2019Sullivan M, Faitli B, Mellerio JE, Fawkes R, Wood M, et al. Foot care in epidermolysis bullosa: evidence-based guideline. Br J Dermatol. 2020;182:593\u2013604.","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"3635_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/scd.12511","volume":"40","author":"S Kr\u00e4mer","year":"2020","unstructured":"Kr\u00e4mer S, Lucas J, Gamboa F, Pe\u00f1arrocha Diago M, Pe\u00f1arrocha Oltra D, Guzm\u00e1n-Letelier M, et al. Clinical practice guidelines: oral health care for children and adults living with epidermolysis bullosa. Spec Care Dentist. 2020;40(Suppl 1):3\u201381.","journal-title":"Spec Care Dentist"},{"key":"3635_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13023-020-01403-x","volume":"15","author":"JE Mellerio","year":"2020","unstructured":"Mellerio JE, El Hachem M, Bellon N, Zambruno G, Buckova H, Autrata R, et al. Emergency management in epidermolysis bullosa: consensus clinical recommendations from the European reference network for rare skin diseases. Orphanet J Rare Dis. 2020;15:142.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR23","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1111\/jdv.17629","volume":"35","author":"C Has","year":"2021","unstructured":"Has C, El Hachem M, Bu\u010dkov\u00e1 H, Fischer P, Friedov\u00e1 M, Greco C, et al. Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases. J Eur Acad Dermatol Venereol. 2021;35:2349\u201360.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3635_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13023-020-01640-0","volume":"16","author":"A King","year":"2021","unstructured":"King A, Hanley H, Popenhagen M, Perez F, Thompson K, Purvis D, et al. Supporting sexuality for people living with epidermolysis bullosa: clinical practice guidelines. Orphanet J Rare Dis. 2021;16:9.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13023-021-01997-w","volume":"16","author":"A Weisman","year":"2021","unstructured":"Weisman A, Chan JM, LaPointe C, Sjoholm K, Steinau K, Artus K, et al. Physiotherapy for epidermolysis bullosa: clinical practice guidelines. Orphanet J Rare Dis. 2021;16:406.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13023-022-02282-0","volume":"17","author":"R Box","year":"2022","unstructured":"Box R, Bernardis C, Pleshkov A, Jessop N, Miller C, Skye J, et al. Hand surgery and hand therapy clinical practice guideline for epidermolysis bullosa. Orphanet J Rare Dis. 2022;17:406.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/bjd.20809","volume":"186","author":"DT Greenblatt","year":"2022","unstructured":"Greenblatt DT, Pillay E, Snelson K, Saad R, Torres Pradilla M, Widhiati S, et al. Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline. Br J Dermatol. 2022;186:620\u201332.","journal-title":"Br J Dermatol"},{"key":"3635_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13023-022-02448-w","volume":"18","author":"C Liy-Wong","year":"2023","unstructured":"Liy-Wong C, Tarango C, Pope E, Coates T, Bruckner AL, Feinstein JA, et al. Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa. Orphanet J Rare Dis. 2023;18:38.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21061\/jcte.v15i2.702","volume":"15","author":"RL Custer","year":"1999","unstructured":"Custer RL, Scarcella JA, Stewart BR. The modified delphi technique\u2014a rotational modification. J Career Tech Educ. 1999;15:50\u20138.","journal-title":"J Career Tech Educ"},{"key":"3635_CR30","doi-asserted-by":"crossref","unstructured":"Keeney S, Hasson F, Mckenna H. How to get started with the Delphi technique? In: The Delphi technique in nursing and health research. Chichester: Wiley; 2010. p. 43\u201368.","DOI":"10.1002\/9781444392029.ch4"},{"key":"3635_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376\u201380.","journal-title":"BMJ"},{"key":"3635_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13023-023-02796-1","volume":"18","author":"KM Stepien","year":"2023","unstructured":"Stepien KM, Broomfield A, Cole D, Deegan PB, Forshaw-Hulme S, Hughes D, et al. Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel. Orphanet J Rare Dis. 2023;18:203.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13023-023-02631-7","volume":"18","author":"S Ingen-Housz-Oro","year":"2023","unstructured":"Ingen-Housz-Oro S, Schmidt V, Ameri MM, Abe R, Brassard A, Mostaghimi A, et al. Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus. Orphanet J Rare Dis. 2023;18:33.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, Wales PW. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67:401\u20139.","journal-title":"J Clin Epidemiol"},{"key":"3635_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/jdv.17060","volume":"35","author":"S Rossi","year":"2021","unstructured":"Rossi S, Castiglia D, Pisaneschi E, Diociaiuti A, Stracuzzi A, Cesario C, et al. Immunofluorescence mapping, electron microscopy and genetics in the diagnosis and sub-classification of inherited epidermolysis bullosa: a single-centre retrospective comparative study of 87 cases with long-term follow-up. J Eur Acad Dermatol Venereol. 2021;35:1007\u201316.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3635_CR36","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1542\/neo.22-7-e438","volume":"22","author":"AW Lucky","year":"2021","unstructured":"Lucky AW, Whalen J, Rowe S, Marathe KS, Gorell E. Diagnosis and care of the newborn with epidermolysis bullosa. NeoReviews. 2021;22:e438\u201351.","journal-title":"NeoReviews"},{"key":"3635_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13052-022-01252-3","volume":"48","author":"C Retrosi","year":"2022","unstructured":"Retrosi C, Diociaiuti A, De Ranieri C, Corbeddu M, Carnevale C, Giancristoforo S, et al. Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center. Ital J Pediatr. 2022;48:58.","journal-title":"Ital J Pediatr"},{"key":"3635_CR38","unstructured":"Denyer J, Pillay E, Clapham J. Best practice guidelines for skin and wound care in epidermolysis bullosa. An International Consensus. Wounds International; 2017. https:\/\/www.woundsinternational.com\/resources\/details\/best-practice-guidelines-skin-and-wound-care-in-epidermolysis-bullosa. Accessed 16 Dec 2022."},{"key":"3635_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.det.2010.01.010","volume":"28","author":"L Haynes","year":"2010","unstructured":"Haynes L. Nutrition for children with epidermolysis bullosa. Dermatol Clin. 2010;28:289\u2013301.","journal-title":"Dermatol Clin"},{"key":"3635_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/bjd.16139","volume":"179","author":"APC Zidorio","year":"2018","unstructured":"Zidorio APC, Dutra ES, Castro LCG, Carvalho KMB. Effectiveness of gastrostomy for improving nutritional status and quality of life in patients with epidermolysis bullosa: a systematic review. Br J Dermatol. 2018;179:42\u20139.","journal-title":"Br J Dermatol"},{"key":"3635_CR41","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1365-2133.2008.08507.x","volume":"158","author":"EB Freeman","year":"2008","unstructured":"Freeman EB, K\u00f6glmeier J, Martinez AE, Mellerio JE, Haynes L, Sebire NJ, et al. Gastrointestinal complications of epidermolysis bullosa in children. Br J Dermatol. 2008;158:1308\u201314.","journal-title":"Br J Dermatol"},{"key":"3635_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MPG.0b013e31812f5667","volume":"46","author":"JD Fine","year":"2008","unstructured":"Fine JD, Johnson LB, Weiner M, Suchindran C. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. J Pediatr Gastroenterol Nutr. 2008;46:147\u201358.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3635_CR43","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MPG.0000000000002820","volume":"71","author":"E Pope","year":"2020","unstructured":"Pope E, Mansour M, Berseneva M, Liy-Wong C, Salas J, Fuentes I, et al. Outcomes and predictors for re-stenosis of esophageal stricture in epidermolysis bullosa: a multicenter cohort study. J Pediatr Gastroenterol Nutr. 2020;71:310\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3635_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s40272-014-0086-0","volume":"16","author":"A Zanini","year":"2014","unstructured":"Zanini A, Guez S, Salera S, Farris G, Morandi A, Gentilino V, et al. Oral viscous budesonide as a first-line approach to esophageal stenosis in epidermolysis bullosa: an open-label trial in six children. Paediatr Drugs. 2014;16:391\u20135.","journal-title":"Paediatr Drugs"},{"key":"3635_CR45","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/pde.15406","volume":"40","author":"ML Bageta","year":"2023","unstructured":"Bageta ML, Yerlett N, Rybak A, Balboa PL, Petrof G, Martinez AE. Management of acute sloughing of the esophageal lining in patients with dystrophic epidermolysis bullosa\u2014a series of six pediatric patients. Pediatr Dermatol. 2023;40:1010\u20134.","journal-title":"Pediatr Dermatol"},{"key":"3635_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clnu.2019.02.023","volume":"39","author":"S Salera","year":"2020","unstructured":"Salera S, Tadini G, Rossetti D, Grassi FS, Marchisio P, Agostoni C, et al. A nutrition-based approach to epidermolysis bullosa: causes, assessments, requirements and management. Clin Nutr. 2020;39:343\u201352.","journal-title":"Clin Nutr"},{"key":"3635_CR47","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.nut.2013.05.008","volume":"29","author":"K Huysentruyt","year":"2013","unstructured":"Huysentruyt K, Alliet P, Muyshont L, Rossignol R, Devreker T, Bontems P, et al. The STRONG(kids) nutritional screening tool in hospitalized children: a validation study. Nutrition. 2013;29:1356\u201361.","journal-title":"Nutrition"},{"key":"3635_CR48","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/bjd.18475","volume":"182","author":"A Reimer","year":"2020","unstructured":"Reimer A, Hess M, Schwieger-Briel A, Kiritsi D, Schauer F, Schumann H, et al. Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study. Br J Dermatol. 2020;182:1437\u201348.","journal-title":"Br J Dermatol"},{"key":"3635_CR49","unstructured":"Hubbard L, Jones R. Preventative nutritional care guideline: Constipation management for children and adults with epidermolysis bullosa. DEBRA International, 2019. https:\/\/af13d689-15eb-4199-8733e91a7bb8ae3f.usrfiles.com\/ugd\/af13d6_ef4673a60a34476093489b47bc5b0921.pdf. Accessed 16 Dec 2022."},{"key":"3635_CR50","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/pde.15239","volume":"40","author":"C Tarango","year":"2023","unstructured":"Tarango C, Quinn CT, Augsburger B, Lucky AW. Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa. Pediatr Dermatol. 2023;40:288\u201393.","journal-title":"Pediatr Dermatol"},{"key":"3635_CR51","first-page":"1277","volume":"82","author":"Y Bachir","year":"2022","unstructured":"Bachir Y, Daruich A, Marie C, Robert MP, Bremond-Gignac D. Eye involvement and management in inherited epidermolysis bullosa. Drugs. 2022;82:1277\u201385.","journal-title":"Drugs"},{"key":"3635_CR52","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/jdv.16022","volume":"34","author":"A Filoni","year":"2020","unstructured":"Filoni A, Cicco G, Lospalluti L, Maglietta A, Foti C, Annichiarico G, et al. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study. J Eur Acad Dermatol Venereol. 2020;34:1707\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3635_CR53","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13023-019-1262-7","volume":"14","author":"A Diociaiuti","year":"2019","unstructured":"Diociaiuti A, Steinke H, Nystr\u00f6m A, Schwieger-Briel A, Meiss F, Pfannenberg C, et al. EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2019;14:278.","journal-title":"Orphanet J Rare Dis"},{"key":"3635_CR54","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1001\/jamadermatol.2020.0304","volume":"156","author":"A Piccerillo","year":"2020","unstructured":"Piccerillo A, El Hachem M, De Vito R, De Luca EV, Peris K. Pembrolizumab for treatment of a patient with multiple cutaneous squamous cell carcinomas and recessive dystrophic epidermolysis bullosa. JAMA Dermatol. 2020;156:708\u201310.","journal-title":"JAMA Dermatol"},{"key":"3635_CR55","doi-asserted-by":"publisher","first-page":"adv4870","DOI":"10.2340\/actadv.v103.4870","volume":"103","author":"L Trefzer","year":"2023","unstructured":"Trefzer L, Hess ME, Scholten L, Technau-Hafsi K, Meiss F, Boerries M, et al. Variable outcome of immunotherapy in advanced multiple cutaneous squamous cell carcinomas in two patients with recessive dystrophic epidermolysis bullosa. Acta Derm Venereol. 2023;103:adv4870.","journal-title":"Acta Derm Venereol"},{"key":"3635_CR56","doi-asserted-by":"publisher","first-page":"e0274072","DOI":"10.1371\/journal.pone.0274072","volume":"17","author":"G Rodari","year":"2022","unstructured":"Rodari G, Guez S, Salera S, Ulivieri FM, Tadini G, Brena M, et al. A single-centre study on predictors and determinants of pubertal delay and growth impairment in epidermolysis bullosa. PLoS ONE. 2022;17:e0274072.","journal-title":"PLoS ONE"},{"key":"3635_CR57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/pde.15136","volume":"40","author":"H Wasserman","year":"2023","unstructured":"Wasserman H, Dumenigo A, Hornung L, Augsburger B, Marathe K, Lucky AW. Prevalence of delayed puberty and low bone density in patients with epidermolysis bullosa: insight from a large single center\u2019s experience. Pediatr Dermatol. 2023;40:100\u20136.","journal-title":"Pediatr Dermatol"},{"key":"3635_CR58","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/exd.14252","volume":"30","author":"M Kang","year":"2021","unstructured":"Kang M, Chen JSC, Radjenovic M, Yang A, Feng GHY, Murrell DF. An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: a cross-sectional study. Exp Dermatol. 2021;30:1675\u201385.","journal-title":"Exp Dermatol"},{"key":"3635_CR59","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/exd.13771","volume":"28","author":"JS Chen","year":"2019","unstructured":"Chen JS, Yang A, Murrell DF. Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: an evidence-based review. Exp Dermatol. 2019;28:1122\u201330.","journal-title":"Exp Dermatol"},{"key":"3635_CR60","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ekir.2020.10.038","volume":"6","author":"E Hughley","year":"2020","unstructured":"Hughley E, Nehus EJ, VandenHeuvel K, Augsburger BD, Jain NG, Lucky AW. Glomerulonephritis in youth with dystrophic epidermolysis bullosa. Kidney Int Rep. 2020;6:538\u201343.","journal-title":"Kidney Int Rep"},{"key":"3635_CR61","doi-asserted-by":"publisher","first-page":"e2021051","DOI":"10.5826\/dpc.1103a51","volume":"11","author":"N Cicek","year":"2021","unstructured":"Cicek N, Yildiz N, Asadov R, Yucelten AD, Tugtepe H, Alpay H. Kidney and urinary tract involvement in epidermolysis bullosa: Is routine follow-up necessary? Dermatol Pract Concept. 2021;11:e2021051.","journal-title":"Dermatol Pract Concept"},{"key":"3635_CR62","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bjd.19496","volume":"184","author":"M Papanikolaou","year":"2021","unstructured":"Papanikolaou M, Onoufriadis A, Mellerio JE, Nattkemper LA, Yosipovitch G, Steinhoff M, McGrath JA. Prevalence, pathophysiology and management of itch in epidermolysis bullosa. Br J Dermatol. 2021;184:816\u201325.","journal-title":"Br J Dermatol"},{"key":"3635_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/jdv.17671","volume":"36","author":"D Darbord","year":"2022","unstructured":"Darbord D, Hickman G, Pironon N, Barbieux C, Bonnet-des-Claustres M, Titeux M, et al. Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity. J Eur Acad Dermatol Venereol. 2022;36:133\u201343.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3635_CR64","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bjae.2017.11.005","volume":"18","author":"L Bowen","year":"2018","unstructured":"Bowen L, Burtonwood MT. Anaesthetic management of children with epidermolysis bullosa. BJA Educ. 2018;18:41\u20135.","journal-title":"BJA Educ"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03635-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03635-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03635-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T17:00:24Z","timestamp":1742144424000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03635-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,16]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3635"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03635-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,16]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MEH, AD, and GZ have been invited speakers in a meeting organized by Chiesi Global Rare Diseases, MEH is a member of the advisory board of Krystal Biotech. DB, MB, LL, CM, IN, KP, and GT declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}